ARTICLE | Company News
Samaritan, Georgetown University deal
September 20, 2004 7:00 AM UTC
The university granted LIV an exclusive worldwide license to develop and market SP-08 to treat Alzheimer's disease (AD). LIV said in vitro test results suggest the compound has neuroprotective charact...